SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015842
Filing Date
2023-09-18
Accepted
2023-09-18 08:35:23
Documents
15
Period of Report
2023-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enfn-20230915x8k.htm   iXBRL 8-K 51904
2 EX-10.1 enfn-20230915xex10d1.htm EX-10.1 1377828
3 EX-99.1 enfn-20230915xex99d1.htm EX-99.1 7427
4 GRAPHIC enfn-20230915xex99d1001.jpg GRAPHIC 3300
  Complete submission text file 0001558370-23-015842.txt   1796763

Data Files

Seq Description Document Type Size
5 EX-101.SCH enfn-20230915.xsd EX-101.SCH 3120
6 EX-101.LAB enfn-20230915_lab.xml EX-101.LAB 16578
7 EX-101.PRE enfn-20230915_pre.xml EX-101.PRE 10711
9 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20230915x8k_htm.xml XML 5062
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 231260204
SIC: 7372 Services-Prepackaged Software
Office of Technology